![Woo-Jin Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 19 999 $ au 31/07/2026
Woo-Jin Kim formerly worked at KB Insurance Co., Ltd., as President & Co-Chief Executive Officer and SAMSUNG PHARMACEUTICAL Co., Ltd., as Independent Director.
Mr. Kim received his graduate degree from Seoul National University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENOLUTION, Inc.
 GENOLUTION, Inc. BiotechnologyHealth Technology Develops new drugs 0,11% | 31/07/2026 | 22 000 ( 0,11% ) | 19 999 $ | 31/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| SAMSUNG PHARM. CO., LTD. | Directeur/Membre du Conseil | - |
| KB INSURANCE CO LTD | President | 04/07/2012 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
KB Insurance Co., Ltd.
 KB Insurance Co., Ltd. Multi-Line InsuranceFinance Operates as a non-life insurance carrier | Finance |
SAMSUNG PHARMACEUTICAL Co., Ltd.
 SAMSUNG PHARMACEUTICAL Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
